Provided By GlobeNewswire
Last update: Oct 14, 2024
MENLO PARK, Calif., Oct. 14, 2024 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences,” or the “Company”), an eyecare technology company focused on developing and commercializing innovative, interventional technologies that elevate the standard of care, announced today that a new study titled, Impact of TearCare on Reading Speed in Patients with Dry Eye Disease, has been published in the peer-reviewed journal Clinical Ophthalmology.
NASDAQ:SGHT (7/24/2025, 10:38:22 AM)
3.76
-0.02 (-0.53%)
Find more stocks in the Stock Screener